Sonoma Pharmaceuticals SNOA 深 沪
等待开盘 05-21 09:30:00 美东时间
1.07
+0.060
+5.94%
华盛通- 最 高1.10
- 今 开1.01
- 成交量 44.72万股
- 最 低 1.01
- 昨 收 1.01
- 总市值 371.67万
- 52周最高 6.9199
- 市盈率 静 --
- 换手率 12.88%
- 52周最低 0.8501
- 委 比 72.74%
- 总股本 347.36万
- 历史最高 1484.64
- 量 比 3.76
- 振 幅 8.91%
- 历史最低 0.8501
- 每 手 1
- 风险率 0.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sonoma Pharmaceuticals shares are trading higher after the company entered an agreement with Dawson James Securities to sell 2,962,962 units at $1.35 per unit.
Sonoma Pharmaceuticals shares are trading higher after the company entered an a...
05-02 02:20
What's Going On With Sonoma Pharma Stock Monday?
Sonoma Pharmaceuticals (SNOA) shares slide following a $4M public offering priced at $1.35. Get the latest stock news here.
04-27 21:54
Sonoma Pharmaceuticals Prices Offering Of 2,962,963 Shares And Accompanying Warrants At $1.35 Per Unit
Sonoma Pharmaceuticals Prices Offering Of 2,962,963 Shares And Accompanying War...
04-24 21:33
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
Sonoma Pharmaceuticals Signs U.S. Microcyn Supply Agreement
Sonoma Pharmaceuticals ( ($SNOA) ) has provided an update. On April 8, 2026, So...
04-09 21:34
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS
Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its burn relief hydrogel in CVS and Walmart stores.
03-27 14:35
Shares of pharmaceutical companies are trading lower amid overall market weakness due to the ongoing conflict in the Middle East.
Shares of pharmaceutical companies are trading lower amid overall market weakne...
03-06 03:56
Sonoma Pharmaceuticals Q3 EPS $(0.48) Misses $(0.31) Estimate, Sales $4.349M Beat $4.326M Estimate
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.31) by 54.84 percent. This is a 23.81 percent increase over losses of $(0.63) per
02-11 06:25
Sonoma Pharmaceuticals Q3 revenue rises 22%
Sonoma Pharmaceuticals Q3 revenue rises 22% Overview Healthcare product maker's fiscal Q3 revenue rose 22% yr/yr Net loss and EBITDAS loss decreased for fiscal Q3 compared to last year Company expanded distribution channels and strengthened leadership Outlook Sonoma Pharmaceuticals did not provide s
02-11 05:18
BRIEF-Sonoma Pharmaceuticals Q3 Net Income USD -600 Thousand
BRIEF-Sonoma Pharmaceuticals Q3 Net Income USD -600 Thousand Feb 10 (Reuters) - Sonoma Pharmaceuticals Q3 revenue USD 4.3 million. Q3 gross profit USD 1.6 million Q3 operating expenses USD 2.3 million
02-11 05:11
